Quantcast

LEGAL NEWSLINE

Monday, March 18, 2024

Catalent Pharma Solutions alleged to have terminated director in retaliation for reports

Lawsuits
Wrongful term 09

TRENTON, NJ (Legal Newsline) – A Kentucky woman alleges she was terminated in retaliation by her pharmaceutical company employer after reporting allegedly unlawful activity.

Annette Wagner filed a complaint on June 1 in the U.S. District Court for the District of New Jersey against Catalent Pharma Solutions LLC over alleged violation of the New Jersey Conscientious Employee Protection Act and other counts.

According to the complaint, the plaintiff was director of product development for the defendant and was hired in July 2016. She alleges she was wrongfully terminated in June 2017 after reporting allegedly wrongful and unlawful acts at the defendant's drug production facility in Kentucky. 

The plaintiff holds Catalent Pharma Solutions LLC responsible because the defendant allegedly retaliated against her by treating her differently in the workplace and terminating her employment because she objected to the defendant's allegedly unlawful acts.

The plaintiff requests a trial by jury and seeks judgment for compensatory and punitive damages, reasonable attorneys' fees, costs of suit, pre- and post-judgment interest, and such other relief as the court may deem fair and just. She is represented by Neil L. Henrichsen of Henrichsen Siegel PLLC in Washington, D.C.

U.S. District Court for the District of New Jersey case number 3:18-cv-10065-PGS-DEA

More News